Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure.

Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, Angermann CE, Ertl G, Bauersachs J.

Cardiovasc Res. 2003 Mar;57(3):749-56.

PMID:
12618236
2.

Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats.

Yoshiyama M, Omura T, Takeuchi K, Kim S, Shimada K, Yamagishi H, Teragaki M, Akioka K, Iwao H, Yoshikawa J.

J Mol Cell Cardiol. 2001 Apr;33(4):799-810.

PMID:
11273732
3.

Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction.

Matsumoto R, Yoshiyama M, Omura T, Kim S, Nakamura Y, Izumi Y, Akioka K, Iwao H, Takeuchi K, Yoshikawa J.

Circ J. 2004 Apr;68(4):376-82.

4.

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.

Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, Kelly RA.

J Clin Invest. 1999 Aug;104(3):271-80.

5.
6.

Effects of central injection of angiotensin-converting-enzyme inhibitor and angiotensin type 1 receptor antagonist on the brain NF-kappaB and AP-1 activities of rats given LPS.

Watanabe K, Taniguchi M, Miyoshi M, Shimizu H, Imoto T, Sato K, Watanabe T.

Peptides. 2006 Jun;27(6):1538-46. Epub 2005 Dec 13.

PMID:
16356591
7.
8.
9.

Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.

Strand ME, Herum KM, Rana ZA, Skrbic B, Askevold ET, Dahl CP, Vistnes M, Hasic A, Kvaløy H, Sjaastad I, Carlson CR, Tønnessen T, Gullestad L, Christensen G, Lunde IG.

FEBS J. 2013 May;280(10):2228-47. doi: 10.1111/febs.12161. Epub 2013 Feb 24.

10.

Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.

Müller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, Theuer J, Breu V, Mackman N, Luther T, Schneider W, Gulba D, Ganten D, Haller H, Luft FC.

Am J Pathol. 2000 Jul;157(1):111-22.

11.

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.

Fiebeler A, Schmidt F, Müller DN, Park JK, Dechend R, Bieringer M, Shagdarsuren E, Breu V, Haller H, Luft FC.

Hypertension. 2001 Feb;37(2 Pt 2):787-93.

12.

Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support.

Grabellus F, Levkau B, Sokoll A, Welp H, Schmid C, Deng MC, Takeda A, Breithardt G, Baba HA.

Cardiovasc Res. 2002 Jan;53(1):124-30.

PMID:
11744020
13.

Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion.

Zhong C, Zhou Y, Liu H.

Anesthesiology. 2004 Mar;100(3):540-6.

PMID:
15108966
14.
15.
16.

[Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].

Liu XM, Jia Z, Zhou ZQ, Xu JG.

Zhonghua Yi Xue Za Zhi. 2007 Sep 18;87(35):2463-7. Chinese.

PMID:
18067805
17.

S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.

Volz HC, Laohachewin D, Seidel C, Lasitschka F, Keilbach K, Wienbrandt AR, Andrassy J, Bierhaus A, Kaya Z, Katus HA, Andrassy M.

Basic Res Cardiol. 2012 Mar;107(2):250. doi: 10.1007/s00395-012-0250-z. Epub 2012 Feb 10.

PMID:
22318783
18.
19.
20.

Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6.

Rohrbach S, Engelhardt S, Lohse MJ, Werdan K, Holtz J, Muller-Werdan U.

Mol Med. 2007 Nov-Dec;13(11-12):605-14.

Supplemental Content

Support Center